Literature DB >> 12088473

Prevalence of pain among nursing home residents in rural New South Wales.

William J McClean1, Nick H Higginbotham.   

Abstract

OBJECTIVE: To measure the prevalence of pain among residents of rural and regional nursing homes in northern New South Wales and to describe the procedures used for pain management.
DESIGN: Cross-sectional survey using interviews and audit of medical records. SETTING AND PARTICIPANTS: 917 nursing home residents in 15 nursing homes within a northern NSW area health service in 1998-1999. MAIN OUTCOME MEASURES: Number of residents experiencing pain at the time of interview; sites of pain and magnitude of pain problem; diagnoses relevant to pain; analgesic prescribing patterns; non-pharmacological treatments for pain; and the extent of pain documentation in nursing records.
RESULTS: The prevalence of pain present at interview was 27.8% (95% CI, 21.8%-33.8%). Women reported pain more often than men (31% v 21%; chi(2)(2) = 5.38; P = 0.02), but pain was not significantly associated with age, length of stay, or diagnoses of arthritis or dementia. Common sites for pain were the limbs, joints and back; 22% of residents reporting pain had no record of analgesic medication, and 16% had had no form of pain treatment ordered. Agreement between the nursing record and the residents' pain symptoms was borderline poor/fair (kappa, 0.24).
CONCLUSIONS: The prevalence of pain is high among nursing home residents in rural NSW who are able to communicate their pain. Descriptive data suggest that pain management activities could be substantially improved.

Entities:  

Mesh:

Year:  2002        PMID: 12088473     DOI: 10.5694/j.1326-5377.2002.tb04620.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  8 in total

Review 1.  Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem.

Authors:  Kirsten Auret; Stephan A Schug
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  [Increasing importance of opioids in geriatrics].

Authors:  M Schuler; P Oster
Journal:  Schmerz       Date:  2005-08       Impact factor: 1.107

3.  Validation of Doloplus-2 among nonverbal nursing home patients--an evaluation of Doloplus-2 in a clinical setting.

Authors:  Karin Torvik; Stein Kaasa; Øyvind Kirkevold; Ingvild Saltvedt; Jacob C Hølen; Peter Fayers; Tone Rustøen
Journal:  BMC Geriatr       Date:  2010-02-20       Impact factor: 3.921

4.  Pain among nursing home patients in the Netherlands: prevalence, course, clinical correlates, recognition and analgesic treatment--an observational cohort study.

Authors:  Martin Smalbrugge; Lineke K Jongenelis; Anne Margriet Pot; Aartjan Tf Beekman; Jan A Eefsting
Journal:  BMC Geriatr       Date:  2007-02-14       Impact factor: 3.921

5.  Silent and suffering: a pilot study exploring gaps between theory and practice in pain management for people with severe dementia in residential aged care facilities.

Authors:  Carmelle Peisah; Judith Weaver; Lisa Wong; Julie-Anne Strukovski
Journal:  Clin Interv Aging       Date:  2014-10-15       Impact factor: 4.458

6.  Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.

Authors:  Ernest A Kopecky; Ben Vaughn; Scott Lagasse; Melinda O'Connor
Journal:  Drugs Aging       Date:  2017-08       Impact factor: 3.923

Review 7.  A Scoping Literature Review of Rural Institutional Elder Care.

Authors:  Mingyang Li; Yibin Ao; Shulin Deng; Panyu Peng; Shuangzhou Chen; Tong Wang; Igor Martek; Homa Bahmani
Journal:  Int J Environ Res Public Health       Date:  2022-08-19       Impact factor: 4.614

Review 8.  The prevalence, impact and management of musculoskeletal disorders in older people living in care homes: a systematic review.

Authors:  Toby O Smith; Rachel Purdy; Sarah K Latham; Sarah R Kingsbury; Graham Mulley; Philip G Conaghan
Journal:  Rheumatol Int       Date:  2015-08-06       Impact factor: 2.631

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.